Skip to main content
SpringerLink
Log in

CASE REPORT: Diabetes Mellitus During Interferon Therapy for Chronic Viral Hepatitis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Fattovich G, Giustina G, Favarato S, Ruol A, Investigators of the Italian Association for the Study of the Liver: A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 24:38–47, 1996

    Google Scholar 

  2. Waguri M, Hanafusa T, Itoh N, Imagawa A, Miyagawa J, Kawata S, Kono N, Kuwajima M, Matsuzawa Y: Occurrence of IDDM during interferon therapy for chronic viral hepatitis. Diabetes Res Clin Pract 23:33–36, 1994

    Google Scholar 

  3. Whitehead RP, Hauschild A, Christophers E, Figlin R: Diabetes mellitus in cancer patients treated with cobination interleukin 2 and α-interferon. Cancer Biother 10:45–51, 1995

    Google Scholar 

  4. Carithers RL Jr, Emerson SS: Therapy of hepatitis C: Metaanalysis of interferon alpha-2b trials. Hepatology 26(Suppl): S83–S88, 1997

    Google Scholar 

  5. Janssen HLA, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxi A, Hadziyanni S: Fatal hepatic decompensation associated with interferon alpha. Br Med J 306:107–108, 1993

    Google Scholar 

  6. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K: Side effects of high dose interferon therapy for chronic hepatitis C. J Hepatol 25:283–291, 1996

    Google Scholar 

  7. Brod SA, Malone M, Darcan S, Papolla M, Nelson L: Ingested interferon α suppresses Type I diabetes in non-obese diabetic mice. Diabetologia 41:1227–1232, 1998

    Google Scholar 

  8. Beals PE, Pozzilli P: Caution is required with interferon α as a potential treatment for Type I diabetes. Diabetologia 42:385, 1999

    Google Scholar 

  9. Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Herrmann G, Berger A, Kusterer K, Teuber G, Cobelli C, Usadel KH: Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon α. Eur J Clin Invest 30:111–121, 2000

    Google Scholar 

  10. Atkinson MA, Maclaren NK: The pathogenesis of insulindependent diabetes mellitus. N Engl J Med 331:1428–1431, 1994

    Google Scholar 

  11. Fabris P, Betterle C, Floreani A, Greggio NA, De Lazzari F, Naccarato R, Chiarmonte M: Development of Type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis. Lancet 340:548, 1992

    Google Scholar 

  12. Gross U, Seifert E: Transient insulin-dependent diabetes mellitus with alpha-interferon therapy for chronic active hepatitis. Z Gastroenterol 31:609–611, 1993

    Google Scholar 

  13. Guerci AP, Guerci P, Lévy-Marchal C, Ongagna J, Ziegler O, Candiloros H, Guerci O, Drouin P: Onset of insulin-dependent diabetes/mellitus/after/interferon-alpha therapy for hairy cell leukaemia. Lancet 343:1167–1168, 1994

    Google Scholar 

  14. Mathieu E, Fain O, Sitbon M, Thomas M: Diabéte autoimmun aprés traitement par interféron alpha. Presse Med 24:238, 1995

    Google Scholar 

  15. Gori A, Caredda F, Franzetti F, Ridolfo A, Rusconi S, Moroni M: Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon α-2a. Lancet 345:1438–1439, 1995

    Google Scholar 

  16. Murakami M, Iriuchijima T, Mori M: Diabetes mellitus and interferon-α therapy. Ann Intern Med 123:318, 1995

    Google Scholar 

  17. Giuntoli P, Mariani S, Avoli D, Giammarco V: Diabete melliti insulino-dependente indotto da interferon-alfa. Minerva Endocrinol 20:243–245, 1995

    Google Scholar 

  18. Chedin P, Cahen-Varsaux J, Boyer N: Non-insulin-dependent diabetes mellitus developing during interferon-α therapy for chronic hepatitis C. Ann Intern Med 125:521, 1996

    Google Scholar 

  19. Shiba T, Morino Y, Tagawa K, Fujino H, Unuma T: Onset of diabetes with high titer anti-GAD antibody after INF therapy for chronic hepatitis. Diabetes Res Clin Pract 30:237–241, 1996

    Google Scholar 

  20. Rostaing L, Oksman F, Izopet J, Baron E, Cisterne JM, Hoff M, Abbal M, Durand D: Serological markers of autoimmunity in renal transplant patients before and after alpha interferon therapy for chronic hepatitis C. Am J Nephrol 16:478–483, 1996

    Google Scholar 

  21. Frankart L, Lejeune D, Donckier J: Diabetes mellitus and interferon therapy. Diabetes Med 14:405, 1997

    Google Scholar 

  22. Fabris P, Betterle C, Greggio NA, Zanchetta R, Bosi E, Biasin MR, de Lalla F: Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol 28:514–517, 1998

    Google Scholar 

  23. Tohda G, Oida K, Higashi S, Hayashi T, Miamory I: Interferon-α and development of Type 1 diabetes. Diabetes Care 21:1774, 1998

    Google Scholar 

  24. Seifarth C, Benninger J, Böhm BO, Wiest-Ladenburger U, Hahn EG, Hensen J: Augmentation der immunantwort gegen inselzell-antigene mi diabetesentwicklung durch interferon-α-therapie bei chronischer hepatitis C. Z Gastroenterol 37:235–239, 1999

    Google Scholar 

  25. Uto H, Matsuoka H, Murata M, et al: A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract 49:101–106, 2000

    Google Scholar 

  26. Bhatti A, McGarrity TJ, Gabbay R: Diabetic ketoacidosis indueced by alpha interferon and ribavirin treatment in a patient with hepatitis C. Am J Gastroenterol 96:604–605, 2001

    Google Scholar 

  27. Eibl N, Gschwantler M, Ferenci P, Eibl M, Weiss W, Schernthaner G: Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-α. Eur J Gastroenterol Hepatol 13:295–298, 2001

    Google Scholar 

  28. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ: Induction of Type 1 diabetes by intereron-α in transgenic mice. Science 260:1942–1946, 1993

    Google Scholar 

  29. Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353–360, 1985

    Google Scholar 

  30. Foulis AK: Interferon-alpha and IDDM: Comment. Diabetologia 39:127, 1996

    Google Scholar 

  31. Koivisto VA, Pelkonen R, Cantell K: Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 38:641–647, 1989

    Google Scholar 

  32. Sobel DO, Ahvazi B: α-Interferon inhibits the development of diabetes in NOD mice. Diabetes 47:1867–1872, 1998

    Google Scholar 

  33. Tanaka H, Shiota G, Kawasaki H: Changes of glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C. J Med 28:335–346, 1997

    Google Scholar 

  34. Allison MED, Wreghitt T, Palmer CR, Alexander GJM: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21:1135–1139, 1994

    Google Scholar 

  35. Özylikan E, Arslan M: Increased prevalence of diabetes mellitus in patients with chronic hepatitis virus infection. Am J Gastroenterol 91:1480–1481, 1997

    Google Scholar 

  36. Kruszynska YT, Harry DS, Bergman RN, Mcintre N: Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia 36:121–128, 1993

    Google Scholar 

  37. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH: Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 32:209–217, 2000

    Google Scholar 

  38. Yoon JW, Austin M, Onodera T, Notkins AL: Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173–1179, 1979

    Google Scholar 

  39. Mason AL, Lau JYN, Hoang N, Qian K, Alexander GJM, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall, Maclaren NK, Perillo RP: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328–333, 1999

    Google Scholar 

  40. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL: Prevalence of Type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592–599, 2000

    Google Scholar 

  41. Grimbert S, Valensi P, Levy-Marshal C, Perret G, Richardet JP, Raffoux C, Trinchet JC, Beaugrand M: High prevalence of diabetes mellitus in patients with chronic hepatitis C. A casecontrol study. Gastroenterol Clin Biol 20:544–548, 1996

    Google Scholar 

  42. Fraser GM, Harman I, Meller N, Niv Y, Porath A: Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 32:526–530, 1996

    Google Scholar 

  43. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG: Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19:846–850, 1995

    Google Scholar 

  44. Petrides AS: Liver disease and diabetes mellitus. Diabetes Rev 2:2–18, 1994

    Google Scholar 

  45. Zeuzem S, Feinman V, Rasenack J, Heathcote J, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ: Peginterferon alpha-2a in patients with chronic hepatitis C. N Engl J Med 343:1666–1672, 2000

    Google Scholar 

  46. Heathcote EJ, Shiffman ML, Cooksley GE, Dusheiko GM, Lee SS, Balart L, Reindollar R, Reddy RK, Wright TL, Lin A, Hoffman J, De Pamphlis J: Peginterferon alpha-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343:1673–1680, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Réanimation, Centre Hospitalier Laennec, 60100, Creil, France

    Ali Mofredj, Denis Grasset, Henri Licht, Sylvie Loison, Bruno Devergie, Renato Demontis & Jean-François Cadranel

  2. Unité de Gastroenterologie et Hépatologie, Centre Hospitalier Eaubonne–Montmorency, Eaubonne, France

    Mehran Howaizi

Authors
  1. Ali Mofredj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehran Howaizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Denis Grasset
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henri Licht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sylvie Loison
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bruno Devergie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Renato Demontis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jean-François Cadranel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mofredj, A., Howaizi, M., Grasset, D. et al. CASE REPORT: Diabetes Mellitus During Interferon Therapy for Chronic Viral Hepatitis. Dig Dis Sci 47, 1649–1654 (2002). https://doi.org/10.1023/A:1015852110353

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015852110353

Search

Navigation